Figure 1.
Excerpt from a detailing reporting form providing information on a detail visit for gabapentin. Some markings (e.g., “032417 Neuro” and “12233” next to “Product: Neurontin”) were annotations entered by Verispan employees to assist with coding and data entry of completed forms.
Table 1.
Characteristics of 116 Detail Visits
Table 2.
Factors Associated with Intention to Increase Future Prescribing or Recommending of Gabapentin